© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Derivatives

Top Section/Ad

Top Section/Ad

Most recent


SSA
Internal restrictions mean SSAs issue fewer CMS-linked notes
SSA
JP Morgan and Dutch pension fund PGGM transacted derivatives margin trade
SSA
◆ Chinese bank treasury shift from USTs to dollar callables considered ◆ Some European SSAs face cross-currency limitations ◆ Previous market staple 'almost non-existent'
Goldman's Hong takes over from Jeroen Krens
More articles/Ad

More articles/Ad

More articles

  • The CFTC has fined BNP Paribas $90m for allegedly attempting to manipulate the USA ISDAFIX benchmark, through messages that used Salt-N-Pepa lyrics such as, “Push it real good,” according to the CFTC order.
  • The US Senate Committee on Agriculture, Nutrition and Forestry has confirmed the nominations of Dawn DeBerry Stump and Dan Michael Berkovitz to serve as commissioners at the Commodity Futures Trading Commission (CFTC).
  • One of the central planks of the UK government’s policy on how the financial services sector would cope with a no-deal Brexit could turn out to be illegal under World Trade Organisation rules, and could be challenged by other WTO members.
  • German exchange group Deutsche Börse has bought a minority stake in fintech company HQLAx and says that it is “likely to acquire further shareholdings” at the end of the year.
  • Venezuela's petro seems destined to hang around like a bad smell rather than drifting into obscurity, as it deserves to. The country's president Nicolás Maduro has made it the basis of his country’s economy. It is an utter farce.
  • Equity strategists at a bulge bracket bank are foreseeing volatility in Bayer’s share price around the time its €4bn mandatorily convertible bond matures next year, particularly because of its legal problems over a Monsanto weedkiller, and are pitching clients a strategy to profit from this, writes Costas Mourselas.